🔗 Share this article Users Coming Off Slimming Injections Put On Weight Four Times Faster Compared to Dieters Weight management often requires long-term strategies. A recent study indicates that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who halt traditional lifestyle programs. Findings released in a major health publication shows that while obese people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation. "Users purchasing these medications should be cognizant of the danger of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb. That rate of regain suggests a return to original weight in about 18 months. Analyzing Approaches The study, which examined dozens of studies involving over 9,000 of participants, compared the outcomes of these new drugs with conventional dieting. Researchers emphasize that individuals who lose weight through diet and exercise usually experience a more gradual creep back—approximately 0.1 kg a month—after stopping. The Reason for the Fast Regain Nutrition scientists propose the mode of action of the drugs explains the amplified regain. GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate hunger. "Artificially providing GLP-1 levels far above than normal could lead to the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist. "Stopping of this hormone supplement means hunger is no longer kept in check, making binge eating far more likely." A Lifelong Issue? The NHS recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications. Professionals say that, considering the significant potential of relapse, the treatment is often ongoing. This perspective is echoed by pharmaceutical companies, who note that the results "underscore the persistent nature of excess weight," comparing it to managing conditions like diabetes. Patient Experiences People who have come off the jabs report a intense resurgence of appetite. "It felt as if a switch that goes on and you become ravenous," recalled one woman. The struggle is compounded if users have not developed permanent dietary or behavioural modifications during treatment. Widespread Adoption Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire remaining high. Use is more common among females than men. The 40s and 50s demographic shows the highest level of interest. A large proportion access the drugs through private prescriptions rather than public health services. Ultimately, clinicians emphasize that while GLP-1 drugs are potent agents for shedding pounds, they are not a magic cure and long-term success hinges on integrated lifestyle changes.
Weight management often requires long-term strategies. A recent study indicates that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who halt traditional lifestyle programs. Findings released in a major health publication shows that while obese people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation. "Users purchasing these medications should be cognizant of the danger of rapid rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb. That rate of regain suggests a return to original weight in about 18 months. Analyzing Approaches The study, which examined dozens of studies involving over 9,000 of participants, compared the outcomes of these new drugs with conventional dieting. Researchers emphasize that individuals who lose weight through diet and exercise usually experience a more gradual creep back—approximately 0.1 kg a month—after stopping. The Reason for the Fast Regain Nutrition scientists propose the mode of action of the drugs explains the amplified regain. GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate hunger. "Artificially providing GLP-1 levels far above than normal could lead to the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist. "Stopping of this hormone supplement means hunger is no longer kept in check, making binge eating far more likely." A Lifelong Issue? The NHS recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications. Professionals say that, considering the significant potential of relapse, the treatment is often ongoing. This perspective is echoed by pharmaceutical companies, who note that the results "underscore the persistent nature of excess weight," comparing it to managing conditions like diabetes. Patient Experiences People who have come off the jabs report a intense resurgence of appetite. "It felt as if a switch that goes on and you become ravenous," recalled one woman. The struggle is compounded if users have not developed permanent dietary or behavioural modifications during treatment. Widespread Adoption Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire remaining high. Use is more common among females than men. The 40s and 50s demographic shows the highest level of interest. A large proportion access the drugs through private prescriptions rather than public health services. Ultimately, clinicians emphasize that while GLP-1 drugs are potent agents for shedding pounds, they are not a magic cure and long-term success hinges on integrated lifestyle changes.